Handbook of Analysis of Oligonucleotides and Related Products
$316.65
- Paperback
512 pages
- Release Date
19 October 2016
Summary
Oligonucleotides represent one of the most significant pharmaceutical breakthroughs in recent years, showing great promise as diagnostic and therapeutic agents for malignant tumors, cardiovascular disease, diabetes, viral infections, and many other degenerative disorders. The Handbook of Analysis of Oligonucleotides and Related Products is an essential reference manual on the practical application of modern and emerging analytical techniques for the analysis of this unique…
Book Details
| ISBN-13: | 9781138198456 |
|---|---|
| ISBN-10: | 1138198455 |
| Author: | Jose V. Bonilla, G. Susan Srivatsa |
| Publisher: | Taylor & Francis Ltd |
| Imprint: | CRC Press |
| Format: | Paperback |
| Number of Pages: | 512 |
| Release Date: | 19 October 2016 |
| Weight: | 920g |
| Dimensions: | 246mm x 174mm |
You Can Find This Book In
What They're Saying
Critics Review
This is a unique resource for guiding the analysis
This is a unique resource for guiding the analysis of oligonucleotide-based drug products. No other single source provides such a comprehensive overview of the necessary analytical techniques that assess the qualitative characteristics of oligonucleotides intended for pharmaceutical use.—Rachel R Chennault, Ph.D.(American College of Clinical Pharmacy), in Doody’s Notes
About The Author
Jose V. Bonilla
Dr. Jose V. Bonilla’s career has been dedicated to the introduction and implementation of cutting-edge analytical technologies such as LC-MS, high-speed gas chromatography, high-speed GPC, online GC, online HPLC, and online near-IR. He has extensive experience in the management of industrial and pharmaceutical analytical laboratories in compliance with regulatory requirements and is the author and coauthor of several peer-reviewed publications.
Dr. G. Susan Srivatsa
has more than 20 years of experience in the development of small molecules, proteins, peptides, and oligonucleotides as therapeutics. She has contributed to the successful development of more than 35 DNA and RNA oligonucleotide drug candidates through various stages of clinical development and has published widely in the area of oligonucleotide analysis in peer-reviewed journals.Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.